AI-generated summary
The authors studied low-intensity laser irradiation given intravenously to 78 of 112 patients with gastroesophageal reflux disease over a 10-day course. They report increased prostaglandin E2 levels, lower esophageal pH-metry measures, and improved quality of life after treatment, though the abstract's conclusion is framed as suggestive rather than definitive.
- Participants
- 112
- Who or what was studied
- Adults aged 19 to 79 years with gastroesophageal reflux disease
- Wavelengths
- 405 nm
- Limits stated in the abstract
- The abstract reports no control group and states the findings are only suggestive, and it describes a single-arm treatment group without a stated comparator.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Power
- 1.5 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.